Drug Trial Radar · NCT04740840
Anti Inflammatory Treatment of Hypertension
Last checked: Nov 19, 2026Latest source record: Feb 5, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
200
Actual
Start
May 1, 2010
Primary completion
Apr 2, 2012
Study completion May 2, 2015
Sponsor
- Lead sponsor
- Affiliated Hospital of North Sichuan Medical CollegeAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- First Hospitals affiliated to the China PLA General Hospital
- First posted
- Feb 5, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To investigate the anti-inflammatory effect of amlodipine and levamlodipine in the treatment of hypertension
Conditions
- Hypertension
Interventions
LevamlodipineDrug
According to the inclusion criteria of the trial, those who met the diagnosis of hypertension were randomly divided into the experimental group and the control group. The experimental group was treated with 2.5mg levamlodipine to lower blood pressure. Abdominal blood was emptying before the start of the trial and at the first and third month of medication.Data on CRP, TNF-α, IL-6, Lp-PLA2 and ATP were collected.
AmlodipineDrug
According to the inclusion criteria, patients who met the diagnosis of hypertension were randomly divided into the experimental group and the control group. The experimental group was given 5mg amlodipine to lower blood pressure. Fasting blood was collected before the trial and during the first and third months of treatment. CRP, TNF-α, IL-6, Lp-PLA2 and ATP data were collected.
Primary outcomes
What the sponsor says the trial is designed to measure.
- After treatment, the blood pressure control of L-amlodipine group was better than that of amlodipine groupTime frame: One month after treatment
- the serum inflammatory factor level of L-amlodipine group was lower than that of amlodipine groupTime frame: One month after treatment
- Serum ATP level can be used to evaluate the anti-inflammatory effect of hypertension drugsTime frame: One month after treatment
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.